A certificate of analysis is a record of selected measurements on a stated sample or lot. Its value depends on traceability, appropriate methods and clear interpretation. A large purity percentage can be useful, but it does not answer every question about a peptide material.

First identify the report's subject. The chemical name, form, lot and sample description should connect to the material actually received. A report for a supplier's reference batch does not automatically describe a later lot or a finished container prepared elsewhere.

Then separate identity, purity and content. A chromatographic area percentage describes a method-specific distribution of detected signals. It is not automatically a mass fraction, total peptide content or confirmation of the sequence. Q2(R2) emphasizes that analytical procedures must be suitable for the measurement they are intended to support. FDA: Q2(R2), validation of analytical procedures

Other quality questions require separate evidence. Sterility and endotoxin-related requirements are distinct from chemical purity; FDA's specifications guidance treats them as separate considerations for relevant products. FDA: Q6A specifications and acceptance criteria A clean chromatogram cannot establish the absence of every biologically important contaminant.

The laboratory's competence matters as well. ISO/IEC 17025 addresses competence, impartiality and consistent laboratory operation. ISO/IEC 17025: laboratory competence requirements A claim about accreditation should be checked for the relevant laboratory and activity rather than treated as a universal guarantee.

A useful review ends with an explicit decision: which required attributes are supported, which are missing and what further testing is needed for the experiment? This article does not certify any lot or convert a research material into a medicine. It provides a way to read analytical evidence without allowing one impressive number to stand in for identity, quantity, contamination control and intended-use suitability.